SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-21-030474
Filing Date
2021-12-03
Accepted
2021-12-03 17:09:02
Documents
110

Document Format Files

Seq Description Document Type Size
1 forms-1.htm   iXBRL S-1 4369919
2 ex5-1.htm EX-5.1 24536
3 ex23-1.htm EX-23.1 5333
4 ex23-3.htm EX-23.3 4054
5 ex5-1_001.jpg GRAPHIC 1847
6 ex5-1_002.jpg GRAPHIC 1846
7 forms-1_001.jpg GRAPHIC 12654
8 forms-1_012.jpg GRAPHIC 161402
9 forms-1_013.jpg GRAPHIC 112382
10 forms-1_014.jpg GRAPHIC 114050
11 forms-1_015.jpg GRAPHIC 49416
  Complete submission text file 0001493152-21-030474.txt   15581029

Data Files

Seq Description Document Type Size
12 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bcyp-20210930.xsd EX-101.SCH 81104
13 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bcyp-20210930_cal.xml EX-101.CAL 84753
14 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bcyp-20210930_def.xml EX-101.DEF 535448
15 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bcyp-20210930_lab.xml EX-101.LAB 606161
16 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bcyp-20210930_pre.xml EX-101.PRE 611903
17 EXTRACTED XBRL INSTANCE DOCUMENT forms-1_htm.xml XML 2232327
Mailing Address 300 W. 41ST STREET SUITE 202 MIAMI BEACH FL 33140
Business Address 300 W. 41ST STREET SUITE 202 MIAMI BEACH FL 33140 (305) 204-3338
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-261496 | Film No.: 211471021
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences